Mexico City: Sputnik V becomes most used vaccine in capital with 3 million inoculations

In Mexico City, more than 3 million people have received Sputnik V vaccination making it most used vaccine in city. Three million vaccine accounts for 40% of all coronavirus vaccines delivered in city, Eduardo Clark, who is General Director of ncia Digital de Invación Pública (ADIP) suggests. Mexico became first country in rth America to approve Russian-made vaccine Sputnik V on February 2, 2021.

As per reports of ticieros Televisa, Mexico City's administration also anunced on February 11, 2022, that people d 30 to 39 will be given Sputnik V vaccine along with AstraZeneca, after previously approving it for people d 40-49 years. In meanwhile, Mexico is facing a huge surge of COVID presently, with over 1,000 deaths on Thursday, country set a new record for fourth wave of coronavirus pandemic.

Sputnik V produces greater and longer-lasting immune response against COVID

A recent study conducted at Lazzaro Spallanzani National Institute of Infectious Diseases in Italy stated that Sputnik V vaccine promotes production of antibodies capable of neutralising Omicron more than two times better than 2 doses of Pfizer vaccine. Sputnik V produces a greater and longer-lasting immune response against COVID, including Omicron variant than many or vaccines, which is enhanced by Sputnik Light booster.

first component of Sputnik V vaccine, Sputnik Light has been approved in over 30 countries with a combined population of over 2.5 billion people, while Sputnik V has been approved in 71 countries with a combined population of over four billion people. Previous research, particularly in Argentina, has shown that Sputnik Light booster can improve protection in circumstances when or vaccinations are ineffective.

3.8 million Russians vaccinated

vaccine was created by Gamaleya Institute, with support of Russian Direct Investment Fund. statistics from 3.8 million Russians who have been vaccinated, Russian-made vaccine has received second-highest number of national regulatory approvals in world, with an estimated efficacy of 97.6%, according to Sputnik. Recently, Argentina President Alberto Fernández stated that he prefers Russian-made vaccine Sputnik V to or vaccines and that he has three doses of vaccine.

(Im: PTI/ Unsplash)